To efficiently introduce bovine papillomavirus type 1 genes into cultured cells, we constructed a hybrid viral genome in which the simian virus 40 early region is replaced with a segment of the bovine papillomavirus type 1 transforming region. High-titer stocks of simian virus 40 virions containing the recombinant genome were produced in monkey cells that express simian virus 40 large tumor antigen. Cells infected with this virus efficiently expressed the bovine papillomavirus type 1 E2 and E5 genes. Expression of the E2 gene caused transactivation of genes linked to the bovine papillomavirus type 1 control region, resulting in up to a 1000-fold induction. At high multiplicity of infection of a cell line containing an integrated reporter gene, most cells were infected and responded to transactivation. Within 48 hr of infection with wild-type virus but not with an open reading frame ES mutant, mouse C127 cells displayed dramatic changes in morphology and growth characteristics similar to those seen in tumorigenic transformation. This system can be used to determine the acute cellular response to introduction of bovine papillomavirus type 1 transforming and regulatory genes; it can also be used to induce foreign genes stably incorporated into cultured mammalian cells.
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Bovine papillomavirus type 1 (BPV1) and other papillomaviruses can induce tumorigenic transformation of established rodent cells growing in culture (1, 2) . Cell transformation by the papillomaviruses is a topic of considerable interest because of the strong association between human papillomavirus infection and some human squamous cell carcinomas, but little is known about the molecular mechanisms of papillomavirus transformation. This deficiency is due in large part to the lack of a cell culture system that allows papillomavirus propagation. Moreover, it is cumbersome to isolate wild-type virus from cow warts, and constructed viral mutants cannot be packaged into virus particles.
Therefore, genetic analysis of transformation by these viruses has been largely restricted to determining the activity of transfected viral genes and mutants in stable transformation assays (3) . In these assays, open reading frames (ORFs) E5 and E6 have been identified as the major BPV1 transforming genes (4) (5) (6) (7) (8) (9) . The 44-amino acid ORF E5 protein is required for efficient focus formation in the established line of mouse C127 cells (4, (10) (11) (12) . The efficiency of transformation is also influenced by expression of ORF E2. The full-length E2 protein transactivates promoters linked to the BPV1 long control region (LCR), whereas separate proteins encoded by the 3' end of ORF E2 antagonize transactivation (5, 6, (13) (14) (15) (16) (17) (18) .
Because stable transformation is the result of relatively infrequent events and probably represents the endpoint of a multistep process, other assays must be developed to identify the virus-induced biochemical events that lead to transformation. To generate virus particles that efficiently infect cells and express BPV1 transforming and regulatory genes, we constructed a BPV1/simian virus 40 (SV40) recombinant viral genome that replicates and is packaged into SV40 virions in permissive monkey cells. Cells infected with this virus efficiently express the BPV1 E2 and E5 genes, and this expression results in transactivation and acute morphologic transformation.
MATERIALS AND METHODS Structure of SV40/BPV Recombinant Plasmids. Standard procedures were used to construct pPava-1 from cloned SV40 and BPV1 DNA [pCC2 (19) and pBPV-142-6 (20), respectively]. pPava-1 consists of the BstEII [nucleotides (nt) 2405]-to-BamHI (nt 4450) small fragment of BPV1 DNA inserted in place of the HindIII (nt 5171)-to-Bcl I (nt 2770) large tumor (T) antigen-coding fragment of SV40 DNA. These viral sequences are cloned into pBR322 at the unique EcoRI site in the SV40 late region. The HindIl, BamHI, and Bcl I sites at the junctions of the DNA fragments were lost, and a Xho I linker was inserted at the junction upstream ofthe BPV1 DNA. To generate pPava-E2aml the BstEII-to-BstXI fragment of pPava-1 was replaced with the corresponding fragment of pBPV-E2am9 (17) . To generate pPava-E5d29, pPava-1 was digested with Spe I and BstXI, and the ends were ligated after they were made blunt enzymatically. This mutant contains a 29-base-pair (bp) deletion (nt 3888-3916).
Preparation of Virus Particles. To generate virus particles, the EcoRI fragments of pPava-1 and its mutants were circularized by ligation at a DNA concentration of 5 ,g/ml and transfected into CMT4 cells (21) by using calcium phosphate. After 4-6 hr, the cells were subjected to glycerol shock as described (18) Establishing the NL-3D Cell Line. Plasmid p407-lac was constructed by replacing the HindIII-to-Hpa I fragment containing the CAT gene-coding sequences from plasmid p407-1 (13) with the BamHI-to-HindIII fragment containing the lacZ coding sequences from plasmid pCH110 (Pharmacia). CV1 cells were cotransfected with plasmid pKOneo and a 5-fold molar excess of p407-lac by the calcium phosphate method. Individual G418-resistant colonies were screened for inducible lacZ expression after infection with Pava-1 by monitoring the color of the culture medium after the addition of 5 mM chlorophenol red-f3-D-galactopyranoside 48 hr after infection. NL-3D cells were cloned from a colony exhibiting high-level induction.
Immunofluorescence of fi-Galactosidase. NL-3D cells on glass slides were infected at a multiplicity of =1000, exposed to 5 mM sodium butyrate for 24 hr, and incubated in normal medium for an additional 24 hr. Indirect immunofluorescence for 8-galactosidase was performed after fixing the cells in methanol for 10 min at -20°C followed by acetone for 1 min at -20°C. Cells that does not affect any of the other ORFs and causes a substantial defect in E2-mediated transactivation (17, 23) . pPava-E5d29 contains a frameshift in BPV1 ORF E5, the gene required for efficient C127 cell focus formation. Hightiter virus stocks were prepared from each of these mutant plasmids, and restriction mapping of viral DNA isolated from infected CMT4 cells confirmed the presence of the mutation and the absence of other alterations (data not shown).
Expression of the E2 Gene After Pava-1 Infection. To demonstrate the expression of a biologically active BPV1 E2 gene product in Pava-infected cells, we performed a transactivation assay using the plasmid p407-1, which contains the BPV-1 LCR linked to the bacterial CAT gene (13) . Expression of the CAT gene from p407-1 requires ORF E2 activity (Fig. 2 , columns A and B) (13) . CV1 cells were transfected with p407-1 and then infected with stocks of Pava-1 or Pava-E2am1. After 48 hr extracts were prepared, and CAT activity was measured in vitro (Fig. 2, columns C To measure lacZ expression in NL-3D cells, an extract was prepared from cells 48 hr after they were mock-infected or infected with stocks of Pava-1 or its derivatives, and /8-galactosidase activity was assayed in an in vitro reaction (Fig.  3) . Enzyme activity was very low in the absence of infection but was dramatically induced by Pava-1 infection. At low multiplicities of infection, the activity was directly propor- tional to the amount of input virus, and at high multiplicity the level of induction approached 100-fold. In this assay, PavaE5d29 was as active as Pava-1, whereas Pava-E2aml was inactive. To monitor infection efficiency, we infected NL-3D cells with Pava-1 at high multiplicity and performed indirect immunofluorescence with a monoclonal antibody directed against f3-galactosidase. Mock-infected NL-3D cells showed very low levels of background fluorescence (Fig. 4B) , whereas the great majority of cells exposed to Pava-1 exhibited a significant diffuse cytoplasmic fluorescence, indicative of E2-mediated transactivation of the lacZ gene in these cells (Fig. 4D) . Thus, Pava-1 infection results in the introduction ofbiologically active BPV1 genes in the majority of cells in the target population.
Expression of the E5 Protein in Pava-Infected Cells. To test whether the BPV1 E5 gene is expressed in Pava-infected cells, induced CMT4 cells were infected, metabolically labeled, and subjected to immunoprecipitation with an anti-E5 peptide antiserum (11) . Immunoprecipitated proteins were visualized by NaDodSO4/PAGE and fluorography (Fig. 5) . Mock-infected CMT4 cells and cells infected with PavaESd29 expressed no E5 protein, whereas Pava-1 and PavaE2aml-infected cells expressed large amounts of the 7-kDa E5 protein. The amount of E5 protein expressed in Pavainfected CMT4 cells is far greater than that seen in C127 mouse cell lines stably transformed by BPV1.
Morphologic Transformation After Pava Infection. We also tested the effect of Pava-1 infection on C127 cells, a standard host for BPV1-mediated transformation. Within 24-48 hr of infection, cells underwent a dramatic morphologic change, in which they became more spindle-shaped and refractile, whereas mock-infected cells remained unchanged (Fig. 6 A  and B) . The infected cells displayed a number of other characteristics of cells stably transformed by BPV1, including the ability to overgrow the monolayer (reaching a saturation density several-fold higher than mock-infected cells), disruption of actin filaments, and rapid acidification of the culture medium; moreover infection stimulated cellular DNA synthesis in cells made quiescent by serum starvation and contact inhibition (data not shown). Transforming activity banded at the density of authentic SV40 virions upon centrifugation in CsCl and was abolished by incubation ofPava-1 with SV40 neutralizing antibody but not by incubation with preimmune serum (data not shown). We have not seen the development of stable transformed foci after repassage of cells acutely transformed by Pava-1 infection. To identify the BPV1 gene(s) required for acute transformation, we tested the two viral mutants. Cells infected with Pava-EMd29 remained flat and were morphologically indistinguishable from mock-infected cells (Fig. 6D) . Thus, the rapid morphologic change caused by Pava-1 infection requires expression of the E5 gene product. Cells infected with Pava-E2aml initially exhibited morphological transformation comparable to that (Fig. 6C) ; however, after several days they appeared to be significantly less transformed than Pava-1-infected cells.
DISCUSSION
To circumvent the block to papillomavirus production in tissue culture, we have developed Pava-1, a recombinant virus that contains BPV1 E2 and E5 genes. Similar approaches have been used to encapsidate a variety of cellular and viral genes (24) (26) . By testing these mutants in the acute assay, we can determine whether acute transformation and stable transformation require the same structural features of the E5 protein.
ORF E2 normally controls BPV1 genes maintained on a plasmid (27) . However, our results show that the E2 gene product can transactivate a responsive element that is integrated into cellular DNA, implying that it has the potential to affect expression of endogenous cellular genes. Therefore, ORF E2 mutations may block transactivation of both cellular genes and viral genes, and both effects may contribute to the transformation defect caused by these mutations. 
